14 specialized isotopes transforming oncology precision in 2026
In the first quarter of 2026, the global medical landscape is facing a seismic shift as advanced alpha-emitting isotopes move from experimental trials to standard clinical protocols. Healthcare systems in North America and Western Europe are prioritizing high-precision ligand therapies to combat late-stage metastatic cancers that were previously deemed untreatable. This surge in adoption is...
0 Comments 0 Shares 264 Views 0 Reviews